DanielleE.WestfallMD

Pathology • Thousand Oaks, CA

Genitourinary Pathology, Anatomic Pathology, Clinical Pathology

TOPA Diagnostics

Join to view full profile

Dr. Westfall is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Westfall's full profile

Already have an account?

Office
351 Rolling Oaks Dr
Ste 100
Thousand Oaks, CA 91361
Phone+1 805-373-8582

Fax+1 805-370-4489

Education & Training

Cedars-Sinai Medical CenterFellowship, Selective Pathology, 2009 - 2010
Cedars-Sinai Medical CenterResidency, Pathology-Anatomic and Clinical, 2005 - 2009
Ohio State University College of MedicineClass of 2005

Certifications & Licensure

CA State Medical License 2006 - 2026
American Board of Pathology Pathology - Anatomic/Pathology - Clinical

Publications & Presentations

PubMed

"Indeterminate" UroVysion Fluorescence In Situ Hybridization Results.
Jing Xu, Danielle E. Westfall, Jean Lopategui
American Journal of Clinical Pathology. 2021-08-04
37 citations
Utility of a triple antibody cocktail intraurothelial neoplasm-3 (IUN-3-CK20/CD44s/p53) and α-methylacyl-CoA racemase (AMACR) in the distinction of urothelial carcinom...
Manju Aron, Daniel Luthringer, Jesse K. McKenney, Donna E. Hansel, Danielle E. Westfall
The American Journal of Surgical Pathology. 2013-12-01
48 citations
Selective Immunohistochemical Markers to Distinguish Between Metastatic High-Grade Urothelial Carcinoma and Primary Poorly Differentiated Invasive Squamous Cell Carcin...
Aaron M. Gruver, Mahul B. Amin, Daniel Luthringer, Danielle Westfall, Komal Arora
Archives of Pathology & Laboratory Medicine. 2012-10-30